Myokardia Stock Return On Asset
MyoKardia fundamentals help investors to digest information that contributes to MyoKardia's financial success or failures. It also enables traders to predict the movement of MyoKardia Stock. The fundamental analysis module provides a way to measure MyoKardia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MyoKardia stock.
MyoKardia |
MyoKardia Company Return On Asset Analysis
MyoKardia's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current MyoKardia Return On Asset | -23.07 |
Most of MyoKardia's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MyoKardia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, MyoKardia has a Return On Asset of -23.07. This is 163.66% higher than that of the Healthcare sector and 2.25% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
MyoKardia Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MyoKardia's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MyoKardia could also be used in its relative valuation, which is a method of valuing MyoKardia by comparing valuation metrics of similar companies.MyoKardia is currently under evaluation in return on asset category among related companies.
MyoKardia Fundamentals
| Return On Equity | -42.7 | |||
| Return On Asset | -23.07 | |||
| Current Valuation | 11.15 B | |||
| Shares Outstanding | 53.32 M | |||
| Shares Owned By Insiders | 2.22 % | |||
| Shares Owned By Institutions | 94.59 % | |||
| Number Of Shares Shorted | 4.63 M | |||
| Price To Earning | (57.57) X | |||
| Price To Book | 14.19 X | |||
| Price To Sales | 253.61 X | |||
| Revenue | 12.4 M | |||
| Gross Profit | (226.17 M) | |||
| EBITDA | (280.21 M) | |||
| Net Income | (276.96 M) | |||
| Cash And Equivalents | 895.88 M | |||
| Cash Per Share | 16.80 X | |||
| Total Debt | 51.61 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 17.98 X | |||
| Book Value Per Share | 15.85 X | |||
| Cash Flow From Operations | (195.1 M) | |||
| Short Ratio | 2.02 X | |||
| Earnings Per Share | (5.66) X | |||
| Price To Earnings To Growth | (0.80) X | |||
| Number Of Employees | 318 | |||
| Beta | 1.83 | |||
| Market Capitalization | 11.99 B | |||
| Total Asset | 81.36 M | |||
| Retained Earnings | (491.37 M) | |||
| Working Capital | 65.67 M | |||
| Current Asset | 77.88 M | |||
| Current Liabilities | 12.21 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MyoKardia in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MyoKardia's short interest history, or implied volatility extrapolated from MyoKardia options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in MyoKardia Stock
If you are still planning to invest in MyoKardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyoKardia's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |